GleamWall
中文EN

RVTY REVVITY, INC.

Laboratory Analytical Instruments · NYSE · SEC CIK 31791 · Fiscal year ends 12/29

Financial factors as of 2026-10-04 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.6%
TTM net income YoY6.6%
TTM EPS YoY12.6%
Revenue 3-yr CAGR1.7%
Net income 3-yr CAGR-30.1%

Margins

Gross margin—
Operating margin12.6%
Net margin8.6%
FCF margin20.1%
EBITDA margin20.9%

Returns

ROE3.5%
ROA2.1%
ROIC (approx.)3.5%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets36.7%
Debt / equity0.36x
Current ratio2.65x
Interest coverage4.04x

Cash quality & payout

Operating cash flow / net income2.59x
Accruals ratio-3.4%
Payout ratio12.4%
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-10-042026Q22026-07-052026Q12026-04-052025Q4*2025-12-282025Q32025-09-282025Q22025-06-292025Q12025-03-302024Q4*2024-12-29
Income statement
Revenue$728.90M$729.69M$711.12M$772.06M$698.95M$720.28M$664.76M$729.37M
Cost of revenue$310.32M$312.82M$323.46M—$324.35M$327.73M$289.22M—
Gross profit$418.58M$416.87M$387.65M—$374.60M$392.56M$375.55M—
R&D expense$48.11M$48.97M$57.89M$58.18M$50.80M$53.27M$53.60M$49.21M
SG&A expense$275.33M$278.58M$253.88M$251.73M$241.91M$248.53M$249.72M$244.33M
Operating income$95.14M$89.32M$75.89M$111.75M$81.90M$90.76M$72.23M$118.75M
Interest expense$20.81M$22.99M$24.72M$23.51M$22.77M$22.94M$22.96M$22.78M
Pretax income$77.68M$63.53M$49.99M$91.56M$55.69M$68.65M$52.38M$94.56M
Income tax$15.06M$10.05M$9.10M-$4.21M$8.46M$13.43M$10.71M$6.17M
Net income$62.30M$51.82M$40.72M$98.36M$46.65M$53.95M$42.24M$94.64M
EBITDA$113.37M$106.48M$180.94M$214.83M$99.88M$108.25M$169.65M$223.78M
EPS (basic)0.560.470.36—0.400.460.35—
EPS (diluted)0.560.470.36—0.400.460.35—
Dividends declared per share0.070.070.070.070.070.070.070.07
Weighted avg. shares (diluted)111.83M111.63M111.88M—115.46M117.54M120.23M—
Balance sheet
Cash & equivalents$592.80M$1.02B$860.32M$919.86M$931.39M$991.85M$1.14B$1.16B
Short-term investments———————$0
Receivables$687.33M$709.17M$691.38M$744.67M$680.26M$661.14M$617.42M$632.40M
Inventory$388.85M$378.50M$387.50M$379.50M$379.92M$388.47M$381.31M$367.59M
Current assets$1.86B$2.30B$2.13B$2.24B$2.14B$2.24B$2.32B$2.35B
PP&E, net$450.87M$456.25M$465.64M$479.25M$497.09M$499.03M$486.71M$482.22M
Goodwill$6.59B$6.61B$6.61B$6.61B$6.60B$6.61B$6.51B$6.46B
Intangibles$2.14B$2.22B$2.31B$2.35B$2.43B$2.51B$2.57B$2.64B
Total assets$11.49B$12.05B$12.00B$12.17B$12.14B$12.36B$12.36B$12.39B
Current liabilities$701.48M$1.28B$1.24B$1.33B$1.22B$671.81M$648.19M$653.10M
Short-term debt$0$572.16M$575.83M$588.83M$583.84M$230,000$242,000$242,000
Long-term debt$2.63B$2.63B$2.63B$2.63B$2.63B$3.21B$3.17B$3.15B
Total debt$2.63B$3.21B$3.21B$3.22B$3.21B$3.21B$3.17B$3.15B
Total liabilities$4.22B$4.82B$4.81B$4.92B$4.76B$4.81B$4.72B$4.73B
Shareholders' equity$7.27B$7.23B$7.18B$7.25B$7.38B$7.56B$7.64B$7.67B
Net debt$2.04B$2.18B$2.35B$2.30B$2.28B$2.22B$2.03B$1.99B
Shares outstanding111.62M111.58M111.63M112.28M114.03M116.33M119.41M120.65M
Cash flow statement
Operating cash flow$166.70M$191.94M$115.23M$181.96M$138.50M$134.32M$128.16M$174.23M
Capital expenditure$14.35M$11.07M$19.77M$20.17M$18.50M$18.87M$15.98M$24.45M
Free cash flow$152.36M$180.87M$95.45M$161.79M$120.00M$115.45M$112.17M$149.78M
Investing cash flow-$15.60M-$3.50M-$78.27M-$20.45M$18.97M-$9.49M-$6.38M-$17.33M
Financing cash flow-$575.61M-$23.16M-$88.89M-$176.31M-$215.07M-$302.48M-$163.66M-$192.99M
Depreciation & amortization$18.23M$17.17M$105.06M$103.08M$17.98M$17.49M$97.42M$105.03M
Stock-based compensation$9.75M$10.73M$8.71M-$4.07M$9.05M$10.13M$7.73M$5.05M
Dividends paid$7.81M$7.81M$7.84M$7.96M$8.13M$8.28M$8.43M$8.54M
Share buybacks$95,000$15.99M$86.50M$168.28M$205.03M$293.91M$153.59M$185.16M

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.